New Markers: Clinical & Pathologic Predictors of DCIS

The specific aim of the CRN2 DCIS Administrative Supplement is to conduct immunohistochemistry and gene expression assays on the remaining subset of DCIS patients with a recurrence (cases) and a matched sample of those who remain disease free (controls) for which these studies were not covered by Core funds under “Clinical and Pathologic Predictors for Recurrence after DCIS”

<< Back to the list of CRN projects

Loading…